Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis

NCT00078793 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00078793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00078793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Registry of Etanercept (Enbrel®) In Children With Juvenile Rheumatoid Arthritis
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
June 30, 2000
Completion date
January 31, 2008
Enrollment
600 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile rheumatoid arthritis